Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF302 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | UNC80 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | CACNB3 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | PMAIP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | HRH3 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | NCAM1 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
mRNA | CCDC177 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
mRNA | ATCAY | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
mRNA | RCOR3 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |